Search Results - Boundy, Keith

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    A Single- and Multiple-Dose Study To Characterize the Pharmacokinetics, Safety, and Tolerability of Imipenem and Relebactam in Healthy Chinese Participants

    A Single- and Multiple-Dose Study To Characterize the Pharmacokinetics, Safety, and Tolerability of Imipenem and Relebactam in Healthy Chinese Participants by Wang, Xiaohong, Liu, Na, Wei, Yudong, Zhang, Shuang, Li, Haiyan, Yan, Bei, Patel, Munjal, Wang, Hui, Boundy, Keith E., Colon-Gonzalez, Francheska, Zang, Yanqiao, Zhao, Xumin

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a β-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants

    Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a β-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants by Rhee, Elizabeth G., Rizk, Matthew L., Calder, Nicole, Nefliu, Marcela, Warrington, Steven J., Schwartz, Michael S., Mangin, Eric, Boundy, Keith, Bhagunde, Pratik, Colon-Gonzalez, Francheska, Jumes, Patricia, Liu, Yang, Butterton, Joan R.

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Erratum for Rhee et al., “Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a β-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants”

    Erratum for Rhee et al., “Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a β-Lactamase Inhibitor, in Combination with Imipenem and Cilastati... by Rhee, Elizabeth G., Rizk, Matthew L., Calder, Nicole, Nefliu, Marcela, Warrington, Steven J., Schwartz, Michael S., Mangin, Eric, Boundy, Keith, Bhagunde, Pratik, Colon-Gonzalez, Francheska, Jumes, Patricia, Liu, Yang, Butterton, Joan R.

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Impact of renal impairment and human organic anion transporter inhibition on pharmacokinetics, safety and tolerability of relebactam combined with imipenem and cilastatin

    Impact of renal impairment and human organic anion transporter inhibition on pharmacokinetics, safety and tolerability of relebactam combined with imipenem and cilastatin by Bhagunde, Pratik, Colon‐Gonzalez, Francheska, Liu, Yang, Wu, Jin, Xu, Shiyao Sherrie, Garrett, Graigory, Jumes, Patricia, Lasseter, Kenneth, Marbury, Thomas, Rizk, Matthew L., Lala, Mallika, Rhee, Elizabeth G., Butterton, Joan R., Boundy, Keith

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Safety and immunogenicity of the measles vector-based SARS-CoV-2 vaccine candidate, V591, in adults: results from a phase 1/2 randomised, double-blind, placebo-controlled, dose-ranging trial

    Safety and immunogenicity of the measles vector-based SARS-CoV-2 vaccine candidate, V591, in adults: results from a phase 1/2 randomised, double-blind, placebo-controlled, dose-ran... by Vanhoutte, Frédéric, Liu, Wen, Wiedmann, Richard T., Haspeslagh, Liesbeth, Cao, Xin, Boundy, Keith, Aliprantis, Antonios, Davila, Michelle, Hartzel, Jonathan, Li, Jianing, McGuire, Mac, Ramsauer, Katrin, Tomberger, Yvonne, Tschismarov, Roland, Brown, Deborah D., Xu, Weifeng, Sachs, Jeffrey R., Russell, Kevin, Stoch, S. Aubrey, Lai, Eseng

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: